The life expectancy of the population is increasing worldwide due to improvements in the
prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 …

Patients lacking humoral response have been suggested to develop a less severe COVID-19,
but there are some reports with a prolonged, relapsing or deadly course. From April 2020, …

Background and aims Obesity is linked to elevated levels of inflammatory serum markers
such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNFa). …

Introduction: The use of dipeptidyl peptidase-4 inhibitors in hospitalized patients is an area of
active research. We aimed to compare the efficacy and the safety of the basal-bolus insulin …

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …

Objectives We aimed to develop and validate a prediction model, based on clinical history
and examination findings on initial diagnosis of coronavirus disease 2019 (COVID-19), to …

Background There is little evidence on the use of sodium−glucose cotransporter 2 (SGLT2)
inhibitors in older patients with heart failure. This work analyzed the clinical efficacy and …

Background The impact of glucagon-like peptide-1 receptor agonists on patients with heart
failure has not been fully described. Our main objective was to evaluate the safety and …

Findings from cardiovascular outcome trials on certain newer glucose-lowering drugs have
shown clear cardiovascular and renal benefits. In this review, we provide an updated …

Obesity, diabetes mellitus, and cardiovascular risk are real challenges in systemic lupus
erythematosus (SLE) clinical practice and research. The evidence of the burden of these health …